IMPORTANT SAFETY INFORMATION FOR APIDRA®
Apidra® is for adults with type 1 or type 2 diabetes for the control of high
blood sugar. Apidra® should normally be used with a longer-acting insulin. Do
not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are
allergic to insulin glulisine.
OptiClik® is a reusable insulin delivery device (insulin pen) for use with a
3-mL Apidra® cartridge (U-100). Needles and the OptiClik® pen must not
be shared.
Apidra® differs from regular human insulin by its rapid onset and shorter
duration of action. When used as a mealtime insulin, Apidra® should be given
within 15 minutes before or within 20 minutes after starting a meal. Due to the
short duration of action of Apidra®, patients also require a longer-acting insulin
or insulin infusion pump therapy. Any change of insulin should be made cautiously
and only under medical supervision. Tell your doctor about all other
medicines and supplements you are taking. Glucose monitoring is recommended for
all patients with diabetes.
Possible side effects may include low blood sugar; injection site reactions, such
as changes in fat tissue at the injection site; and allergic reactions, such as
itching and rash. Less common, but potentially more serious or life-threatening,
is generalized allergy to insulin, including anaphylactic reactions.
When used in a pump, do not mix Apidra® with any other insulin or liquid.
If the pump or infusion set does not work right, you may not receive the right amount
of insulin. Hypoglycemia, hyperglycemia, or ketosis can happen. Problems should
be identified and corrected as quickly as possible.
Exercise or activity level may change the way your body uses insulin. Check with your healthcare provider before you start an exercise program because your dose may need to be changed.
Click here for additional important information for Apidra®.
